Skip to content

Prospective Randomized Trial of Laparoscopic Versus Open Liver Resection for HCC

Prospective Randomized Trial of Laparoscopic Versus Open Liver Resection for Patients With Hepatocellular Carcinoma

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00606385
Acronym
HCC
Enrollment
84
Registered
2008-02-04
Start date
2007-12-31
Completion date
2017-06-30
Last updated
2016-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular Carcinoma

Keywords

Recurrence, Survival, Immunology, Laparoscopy

Brief summary

Short-term outcomes of laparoscopic liver resection is better than those of open liver resection Laparoscopic liver resection is better than open resection in immunological aspects

Detailed description

Advantages and disadvantages of the laparoscopic compared with the open approach for liver resections 1. Advantages 1) Less postoperative ascites production 2) Reduced postoperative pain 3) Feasible in selected cirrhotics who have contraindications to open surgery 4) Less intra-abdominal adhesions (easier salvage transplantation) 5) Shorter recovery time 6) Shorter length of stay 7) Reduced financial cost 2. Disadvantages 1) No manual palpation or exploration of the liver parenchyma possible (with the pure laparoscopic approach) 2) High demand in surgical skill (especially major resections)

Interventions

PROCEDURELiver resection

Laparoscopic or Open hepatectomy

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Radiologically diagnosed hepatocellular carcinoma * Child classification A or B * Aged 20 to 80 * Informed consent taken

Exclusion criteria

* Child classification C * Extrahepatic metastasis * Tumor located in central area or adjacent to middle hepatic vein * Recurred hepatocellular carcinoma * Critically ill patient * Patient with psychiatric disease

Design outcomes

Primary

MeasureTime frame
Recurrence rate2 years after operation

Secondary

MeasureTime frame
Survival2 years after operation

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 18, 2026